About Nodexus
Nodexus is a company based in Berkeley (United States) founded in 2014 by Anand Kesavaraju and Karthik Balakrishnan. Nodexus has raised $31.2 million across 4 funding rounds from investors including HHS, RA Capital and S32. The company has 27 employees as of December 31, 2022. Nodexus offers products and services including NX One, NX One MAX, and NX One PRO. Nodexus operates in a competitive market with competitors including 10X Genomics, Mission Bio, NanoCellect Biomedical, Cellares and ThinkCyte, among others.
- Headquarter Berkeley, United States
- Employees 27 as on 31 Dec, 2022
- Founders Anand Kesavaraju, Karthik Balakrishnan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nodexus Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$31.2 M (USD)
in 4 rounds
-
Latest Funding Round
$30 M (USD), Series A
Dec 16, 2021
-
Investors
HHS
& 7 more
-
Employee Count
27
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nodexus
Nodexus offers a comprehensive portfolio of products and services, including NX One, NX One MAX, and NX One PRO.
Benchtop device for gentle single-cell sorting and dispensing.
System for large particle sorting in organoid and spheroid applications.
Multi-laser configuration for advanced fluorescence-based cell analysis.
People of Nodexus
Unlock access to complete
Unlock access to complete
Advisory Team
3 people
Leadership Team
2 people
Software Development Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of Nodexus
Nodexus has successfully raised a total of $31.2M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $30 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nodexus
Nodexus has secured backing from 8 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, RA Capital and S32.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech startups are funded by S32, a venture capital entity.
|
Locked | Locked | Locked | |
|
Women-led startups are funded through stage-agnostic investments and angel networks.
|
Locked | Locked | Locked | |
|
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
|
Locked | Locked | Locked |
Investor details for Nodexus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nodexus
Investment portfolio details for Nodexus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nodexus
Detailed financials for Nodexus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nodexus Comparisons
Peer comparison for Nodexus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nodexus
Nodexus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, NanoCellect Biomedical, Cellares and ThinkCyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| Locked | Locked | Locked |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| Locked | Locked | Locked |
Develops flow cytometry and cell sorting technology
|
|
| Locked | Locked | Locked |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| Locked | Locked | Locked |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| Locked | Locked | Locked |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
Detailed competitors of Nodexus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nodexus
Complete news archive for Nodexus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nodexus
Nodexus was founded in 2014.
Nodexus is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Karthik Balakrishnan is the current CEO of Nodexus. They have also founded this company.
Nodexus is a funded company, having raised a total of $31.2M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Nodexus is 27.
Nodexus was founded in 2014 in Berkeley, United States, within the biotechnology sector. Microfluidic systems are developed by the company for the detection of metastatic cancer. A single-use cartridge forms the core of the platform technology, enabling isolation of circulating tumor cells. Label-free methods are employed, which minimize sample preparation time. Operations focus on advancing diagnostic tools for oncology applications.
Nodexus's top competitors include 10X Genomics, Mission Bio and NanoCellect Biomedical.
Nodexus offers NX One, NX One MAX, and NX One PRO.
Nodexus has 8 investors. Key investors include HHS, RA Capital, S32, Astia, and Andrew Mendelsohn.